Fanconi anemia differential diagnosis: Difference between revisions
Shyam Patel (talk | contribs) No edit summary |
Shyam Patel (talk | contribs) No edit summary |
||
(4 intermediate revisions by the same user not shown) | |||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Fanconi anemia must be differentiated from [[aplastic anemia]], [[paroxysmal nocturnal hemoglobinuria]], chromosomal breakage syndromes, and hereditary bone marrow failure syndromes ([[dyskeratosis congenita]] and other short telomere syndromes). Each disease has a different pathophysiology, exam findings, and histopathology. | |||
Fanconi | ==Differentiating Fanconi anemia from other diseases== | ||
*Fanconi anemia must be differentiated from other diseases (as noted below).<ref name="pmid24237973">{{cite journal| author=Hartung HD, Olson TS, Bessler M| title=Acquired aplastic anemia in children. | journal=Pediatr Clin North Am | year= 2013 | volume= 60 | issue= 6 | pages= 1311-36 | pmid=24237973 | doi=10.1016/j.pcl.2013.08.011 | pmc=3894991 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24237973 }}</ref><ref name="pmid27069254">{{cite journal| author=Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM et al.| title=The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. | journal=Blood | year= 2016 | volume= 127 | issue= 20 | pages= 2391-405 | pmid=27069254 | doi=10.1182/blood-2016-03-643544 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27069254 }}</ref> | |||
== | ===Differential Diagnosis=== | ||
{| class="wikitable sortable mw-collapsible" | {| class="wikitable sortable mw-collapsible" | ||
|+ | |+ | ||
Line 41: | Line 37: | ||
Eyes- Microphthalmia, ptosis, epicanthal folds, strabismus | Eyes- Microphthalmia, ptosis, epicanthal folds, strabismus | ||
|Inherited defect in DNA Repair causes loss of HSC that leads | |Inherited defect in DNA Repair causes loss of HSC that leads to bone marrow failure. | ||
|Anemia: normocellular or hypercellular bone marrow | |||
to bone marrow failure. | |Gastrointestinal Atresias, imperforate anus, TE fistula, malrotation, | ||
|Anemia | |||
normocellular or hypercellular bone marrow | |||
|Gastrointestinal Atresias, imperforate | |||
anus, TE fistula, malrotation, | |||
Kidney – Abnormal, ectopic, horseshoe, hypoplastic, or absent kidney; hydronephrosis | Kidney – Abnormal, ectopic, horseshoe, hypoplastic, or absent kidney; hydronephrosis | ||
| | | | ||
|FA gene | |FA gene sequencing | ||
sequencing | |Increased chromosomal breakage in response to mitomycin C or diepoxybutane (quite sensitive but not entirely specific) | ||
| | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Acquired Aplastic Anemia | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Acquired Aplastic Anemia | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Infections, mucosal hemorrhage, menorrhagia | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Pallor and petechiae | ||
The liver, spleen, and lymph nodes are typically enlarged in AA, if its enlarged it may suggest alternative diagnosis | The liver, spleen, and lymph nodes are typically enlarged in AA, if its enlarged it may suggest alternative diagnosis | ||
|No known causes 70% cases, known cases are caused | |No known causes 70% cases, known cases are caused by drugs, virus, radiation | ||
by drugs, virus, radiation | |||
| style="background: #F5F5F5; padding: 5px;" |Anemia | | style="background: #F5F5F5; padding: 5px;" |Anemia | ||
normocellular or hypercellular bone marrow | normocellular or hypercellular bone marrow | ||
| style="background: #F5F5F5; padding: 5px;" |Gastrointestinal Atresias, imperforate | | style="background: #F5F5F5; padding: 5px;" |Gastrointestinal Atresias, imperforate anus, TE fistula, malrotation, | ||
anus, TE fistula, malrotation, | |||
Kidney – Abnormal, ectopic, horseshoe, hypoplastic, or absent kidney; hydronephrosis | Kidney – Abnormal, ectopic, horseshoe, hypoplastic, or absent kidney; hydronephrosis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Hypocellular bone marrow | ||
marrow | | style="background: #F5F5F5; padding: 5px;" |Rapid onset | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Paroxysmal nocturnal hemoglobinuria (PNH) | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Paroxysmal nocturnal hemoglobinuria (PNH) | ||
Line 86: | Line 73: | ||
●Erectile dysfunction | ●Erectile dysfunction | ||
●Chest pain | |||
●Thrombosis | ●Thrombosis | ||
Line 121: | Line 108: | ||
•Hyperhidrosis – 15 percent | •Hyperhidrosis – 15 percent | ||
●Ophthalmologic/Epiphora | |||
(excessive tearing/ | (excessive tearing/lacrimal duct stenosis) | ||
●Neurologic/Cognitive | ●Neurologic/Cognitive | ||
Line 135: | Line 120: | ||
•Microcephaly | •Microcephaly | ||
●Pulmonary disease (pulmonary fibrosis) | |||
●Endocrine/Growth/Urologic | ●Endocrine/Growth/Urologic | ||
Line 165: | Line 150: | ||
●Cancer | ●Cancer | ||
|(DC) and telomere related | |(DC) and telomere related disorders, mutations in genes that maintain telomere length in rapidly dividing cells that lead to premature cell death, senescence, or genomic instability, which in turn results | ||
disorders, mutations in genes that maintain telomere length in | |||
rapidly dividing cells that lead | |||
to premature cell death, senescence, or genomic instability, which in turn results | |||
in impaired function and cellular homeostasis in many organs and tissues. | in impaired function and cellular homeostasis in many organs and tissues. | ||
Line 218: | Line 197: | ||
breakage syndrome (''DDX11''). | breakage syndrome (''DDX11''). | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Microcephaly, short stature increased | ||
malignancy | malignancy | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|NBS: chromosomal instability disorder caused by mutations in the nibrin ''(NBN)'' gene | |NBS: chromosomal instability disorder caused by mutations in the nibrin ''(NBN)'' gene | ||
DNA breaks are not efficiently repaired in the absence of | DNA breaks are not efficiently repaired in the absence of fibrin. | ||
oxidative/alkylating stress damages the cells | oxidative/alkylating stress damages the cells | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |No specific findings | ||
| style="background: #F5F5F5; padding: 5px;" |Gastrointestinal Atresias, imperforate | | style="background: #F5F5F5; padding: 5px;" |Gastrointestinal Atresias, imperforate anus, TE fistula, malrotation, | ||
anus, TE fistula, malrotation, | |||
Kidney – Abnormal, ectopic, horseshoe, hypoplastic, or absent kidney; hydronephrosis | Kidney – Abnormal, ectopic, horseshoe, hypoplastic, or absent kidney; hydronephrosis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Abnormal chromosomal breakage test | ||
| style="background: #F5F5F5; padding: 5px;" |No bone | | style="background: #F5F5F5; padding: 5px;" |No bone marrow | ||
marrow | |||
failure | failure | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |De novo myelodysplastic syndrome (MDS) | | style="background: #DCDCDC; padding: 5px; text-align: center;" |De novo myelodysplastic syndrome (MDS) | ||
| style="background: #F5F5F5; padding: 5px;" |MDS can arise de novo or secondary to another bone marrow disorder | | style="background: #F5F5F5; padding: 5px;" |MDS can arise de novo or secondary to another bone marrow disorder | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Bone marrow failure | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Positive | | style="background: #F5F5F5; padding: 5px;" |Positive | ||
chromosomal breakage tests | chromosomal breakage tests | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Negative chromosomal breakage tests | ||
chromosomal breakage tests | |||
|} | |} | ||
Latest revision as of 16:49, 4 May 2019
Fanconi anemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Fanconi anemia differential diagnosis On the Web |
American Roentgen Ray Society Images of Fanconi anemia differential diagnosis |
Risk calculators and risk factors for Fanconi anemia differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shyam Patel [2]
Overview
Fanconi anemia must be differentiated from aplastic anemia, paroxysmal nocturnal hemoglobinuria, chromosomal breakage syndromes, and hereditary bone marrow failure syndromes (dyskeratosis congenita and other short telomere syndromes). Each disease has a different pathophysiology, exam findings, and histopathology.
Differentiating Fanconi anemia from other diseases
Differential Diagnosis
Clinical manifestations | Pathophysiology | Para-clinical findings | Gold standard | Additional findings | ||||
---|---|---|---|---|---|---|---|---|
Lab Findings | Imaging | Histopathology | ||||||
Disease | Symptom | Physical exam | Blood profile | Anamalies | ||||
Fanconi Anemia | Short stature, delicate features, upper limbs absent or hypoplastic thumbs, supernumerary, bifid clinodactyly
infection, petechia, pallor |
Skin – Generalized hyperpigmentation; hypopigmented areas; large freckles, café-au-lait spots
Head – Microcephaly or hydrocephaly; birdlike face, mid-face hypoplasia, Sprengel's deformity of neck, Eyes- Microphthalmia, ptosis, epicanthal folds, strabismus |
Inherited defect in DNA Repair causes loss of HSC that leads to bone marrow failure. | Anemia: normocellular or hypercellular bone marrow | Gastrointestinal Atresias, imperforate anus, TE fistula, malrotation,
Kidney – Abnormal, ectopic, horseshoe, hypoplastic, or absent kidney; hydronephrosis |
FA gene sequencing | Increased chromosomal breakage in response to mitomycin C or diepoxybutane (quite sensitive but not entirely specific) | |
Acquired Aplastic Anemia | Infections, mucosal hemorrhage, menorrhagia | Pallor and petechiae
The liver, spleen, and lymph nodes are typically enlarged in AA, if its enlarged it may suggest alternative diagnosis |
No known causes 70% cases, known cases are caused by drugs, virus, radiation | Anemia
normocellular or hypercellular bone marrow |
Gastrointestinal Atresias, imperforate anus, TE fistula, malrotation,
Kidney – Abnormal, ectopic, horseshoe, hypoplastic, or absent kidney; hydronephrosis |
Hypocellular bone marrow | Rapid onset | |
Paroxysmal nocturnal hemoglobinuria (PNH) | Fatigue
●Dyspnea ●Hemoglobinuria Abdominal pain ●Bone marrow suppression ●Erectile dysfunction ●Chest pain ●Thrombosis ●Renal insufficiency |
Acquired mutation in PIGA gene --> problem in synthesis of
DGI ---> complement mediated Intravascular hemolysis |
Anemia
normocellular or hypercellular bone marrow |
●Hypo/Hyper
/Normo cellular, |
Flow cytometry | |||
Other inherited bone marrow failure syndromes
(Dyskeratosis congenita and other short telomere syndromes) |
Bone marrow failure
Classic mucocutaneous and additional dermatologic findings •Skin dyspigmentation •Nail irregularities •Leukoplakia •Premature graying/hair loss •Hyperhidrosis – 15 percent ●Ophthalmologic/Epiphora (excessive tearing/lacrimal duct stenosis) ●Neurologic/Cognitive •Developmental delay •Ataxia/cerebellar hypoplasia – approximately •Microcephaly ●Pulmonary disease (pulmonary fibrosis) ●Endocrine/Growth/Urologic features •Short stature •Intrauterine growth retardation •Hypogonadism/Undescended testes •Urethral stricture/phimosis •Osteoporosis and related complications |
Unlike Fanconi anemia, individuals with DC do not appear to have impaired fertility
●Dental manifestations (caries) ●Gastroenterologic/Hepatologic manifestations •Esophageal strictures •Liver disease (cirrhosis, fibrosis) or gastroenteropathy ●Cancer |
(DC) and telomere related disorders, mutations in genes that maintain telomere length in rapidly dividing cells that lead to premature cell death, senescence, or genomic instability, which in turn results
in impaired function and cellular homeostasis in many organs and tissues. |
Reticular dysgenesis | Flow cytometry | - chromosomal breakage test. | ||
Drug-induced or infection-associated pancytopenia | ||||||||
Rare syndromes,
Nijmegen breakage syndrome (NBS), Bloom syndrome (BLM), ataxia telangiectasia (ATM), LIG4 syndrome (LIG4), NHEJ1 deficiency (NHEJ1), Seckel syndrome (ATR), cohesinopathies Roberts syndrome (ESCO2) Warsaw breakage syndrome (DDX11). |
Microcephaly, short stature increased
malignancy |
NBS: chromosomal instability disorder caused by mutations in the nibrin (NBN) gene
DNA breaks are not efficiently repaired in the absence of fibrin. oxidative/alkylating stress damages the cells |
No specific findings | Gastrointestinal Atresias, imperforate anus, TE fistula, malrotation,
Kidney – Abnormal, ectopic, horseshoe, hypoplastic, or absent kidney; hydronephrosis |
Abnormal chromosomal breakage test | No bone marrow
failure | ||
De novo myelodysplastic syndrome (MDS) | MDS can arise de novo or secondary to another bone marrow disorder | Bone marrow failure | Positive
chromosomal breakage tests |
Negative chromosomal breakage tests |
References
- ↑ Hartung HD, Olson TS, Bessler M (2013). "Acquired aplastic anemia in children". Pediatr Clin North Am. 60 (6): 1311–36. doi:10.1016/j.pcl.2013.08.011. PMC 3894991. PMID 24237973.
- ↑ Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM; et al. (2016). "The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia". Blood. 127 (20): 2391–405. doi:10.1182/blood-2016-03-643544. PMID 27069254.